Health Canada, a country’s regulating authority in the sphere of healthcare products, has published a guidance document dedicated to the investigation of reported medical device problems. The document provides additional clarifications regarding the applicable regulatory requirements the parties involved should follow. In particular, the document outlines the responsibilities of medical device manufacturers, importers, and distributors in respect of incidents associated with medical devices. It is important to mention that the guidance describes the suggested approach, while the provisions thereof are non-binding in their legal nature.

Closure 

According to the Health Canada guidance, a problem report  investigation may be closed when all corrective and preventive actions and corrections have been completed and evaluated and the identified risks have been eliminated or reduced to an acceptable level. However, since completion of all the aforementioned processes could take time, it is allowed to close a record as soon as the root cause investigation has been completed successfully. In such a case, a decision should be taken about the particular preventive or corrective actions to be taken to address the risks associated with the device. It is further stated that a written procedure on reported problem investigation to be duly developed and implemented by the parties involved in operations with medical devices should contain information about the particular criteria to be applied when determining whether an investigation could be closed. Such a policy should also prescribe that the appropriate review should be carried out by a qualified person to ensure that:

  • All necessary steps have been completed, and
  • The file contains or references records of all actions taken in response to the problem. 

It is important to mention that the present guidance also provides a checklist to be used when evaluating the completeness of a problem report investigation. According to the guidance, the information to be included in the appropriate file should contain the details regarding all the processes the entity has been involved in. Moreover, in case of a file to be maintained by a medical device manufacturer, such information should also contain the details about any decisions taken to address the problem identified.

The authority also states that an importer or distributor could be allowed to decide on the closure of a problem report in case an investigation cannot be completed since the manufacturer responsible for a medical device is not providing necessary information. In such a case, it will be necessary to demonstrate that reasonable efforts have been taken. 

 

Analysis and Trending 

As it is stated by Health Canada, the reports describing problem investigations should be rigorously reviewed to identify potential trends in issues associated with medical devices. The information obtained in the course of trend analysis could be used when taking further decisions regarding the measures to be applied to mitigate the risks associated thereto. 

Thus, the appropriate written procedure to be developed and implemented by all the parties involved should prescribe the way the problem investigation reports should be evaluated regularly, and also the approach to be applied about trend analysis. According to the guidance, where results such as a higher than expected rate of occurrence of a particular failure mode may indicate an unacceptable risk associated with the device, the procedure should require that they be reported to, or utilized by the manufacturer as input for risk management decisions. 

Additional Information 

Apart from the main part covering the points described hereabove, Health Canada’s guidance also contains appendices providing additional details regarding certain specific aspects associated with an investigation of reported medical device problems. In particular, the appendices are highlighting the aspects related to the components an investigation procedure should contain, the components of a standard operating procedure, a checklist to be used by a responsible person when collecting additional information regarding the incident, and recommendations on the way the risk analysis should be performed. As it was mentioned before, the appendices also contain a checklist to be used to evaluate the completeness of a problem report file. 

Elements of an Effective Procedure for Investigation of Reported Incidents

As prescribed by the applicable legislation, all parties involved in operations with medical devices, including medical device manufacturers, importers, and distributors are obliged to develop and implement written procedures describing the way the reported medical device problems should be investigated. One of the appendices to the present Health Canada guidance describes in detail the aspects to be covered by such a procedure. The appropriate table outlines the responsibilities of the parties and pays special attention to the way these responsibilities should be divided among them. According to the guidance, a reported problem investigation policy should contain the following elements: 

  1. Scope. It is stated that the scope of the policy should cover any problems associated with medical devices the party is responsible for, irrespectively of the source from which the information derives. In terms of actions, the procedure should describe all the actions to be taken to address the issue identified, including the actions to be taken by other parties involved. 
  2. Collaboration. The document should describe the way the parties should interact with each other. In particular, it should be described the way the information about the problem should be communicated to the manufacturer for further review. 
  3. Responsibilities. The policy should describe the distribution of responsibilities both inside the company and with other parties involved. 
  4. Risk-based time constraints. The procedure should indicate specific timelines for the actions to be taken for the risk associated with the issue identified. This section should also address the aspects associated with ensuring compliance with mandatory reporting requirements. 
  5. Receiving, recognizing medical device problems. The document should describe the way the information on the safety- and performance-related issues could be obtained from sources other than customer complaints.
  6. Gathering information. This section covers the aspects related to the collection of additional information necessary to complete an investigation. 
  7. Evaluation. The procedure should describe in detail the way the problem should be assessed in terms of its impact on the safety and performance of the medical device in question. This section also covers the aspects to be considered when determining whether the incident is subject to mandatory reporting. 
  8. Mandatory reporting. The document should also contain details about the particular steps to be taken in the course of submitting the appropriate report to the regulating authority. 
  9. Root cause investigation.
  10. Risk decision management. This section should cover all the aspects associated with risks, e.g., risk analysis, risk evaluation, and risk control. 
  11. Collaboration. An additional section describes the way the results of a root cause investigation should be communicated to other parties involved. 
  12. Mandatory reporting (in terms of submitting a final report to the regulating authority). 
  13. Closure. The section addresses the aspects related to the closure of an investigation as described here above. 

In summary, the present guidance document issued by Health Canada highlights the most important aspects related to an investigation of reported medical device problems. The guidance describes the particular steps to be taken by medical device manufacturers and other parties involved in response to information on the safety- and performance-related issues identified.

How Can RegDesk Help?

RegDesk is a next-generation web-based software for medical device and IVD companies. Our cutting-edge platform uses machine learning to provide regulatory intelligence, application preparation, submission, and approvals management globally. Our clients also have access to our network of over 4000 compliance experts worldwide to obtain verification on critical questions. Applications that normally take 6 months to prepare can now be prepared within 6 days using RegDesk Dash(TM). Global expansion has never been this simple.

Sources:

https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/dhp-mps/alt_formats/pdf/compli-conform/prob-report-rapport/gui-0065_md-im_problem_doc-eng.pdf 


Want to know more about our solutions? Speak to a RegDesk Expert today!